Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif

British Journal of Rheumatology

Volumn 35, Issue 6, 1996, Pages 592-594

  Tiwana, H ^a   Wilson, C ^a   Cunningham, P ^b   Binder, A ^c   Ebringer, A ^a,b,d  

^a Infection and Immunity Group   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LISTER HOSPITAL   (United Kingdom)

^d MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Gram negative bacteria; Proteus mirabilis; Rheumatoid arthritis

Indexed keywords

BACTERIUM ANTIBODY;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEUS; PROTEUS MIRABILIS; PSEUDOMONAS; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SERRATIA;

EID: 0029993036     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.6.592     Document Type: Article

References (19)

1. Nepom GT, Byers P, Seyfried CE et al. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using oligonucleotide probes. Arthritis Rheum 1989;33:15-21.
2. Watanabe Y, Tokunaga K, Matsui K et al. Putative amino acid sequence of HLA DRB chain contributing to rheumatoid arthritis susceptibility. J Exp Med 1989;169:2263-8.
3. Uphoff TS, Welch RA. Nucleotide sequencing of the Proteus mirabilis calcium independent haemolysin genes (hpm A and hpm B) reveals sequence similarity with Serratia marcescens haemolysin genes (shl A and shl B). J Bacteriol 1990;172:1206-15.
4. Ebringer A, Cunningham P, Ahmadi K, Wrigglesworth J, Hosseini R, Wilson C. Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and Proteus/Serratia membrane haemolysins. Ann Rheum Dis 1992;51:1245-6.
5. Ebringer A, Ptaszynska T, Corbett M et al. Antibodies to Proteus in rheumatoid arthritis. Lancet 1985;ii:305-7.
6. Deighton CM, Gray J, Bint AJ, Walker DJ. Specificity of the Proteus antibody response in rheumatoid arthritis. Ann Rheum Dis 1992;51:1206-7.
7. Rogers P, Hassan J, Bresnihan B, Feighery C, Whelan A. Antibodies to Proteus in rheumatoid arthritis. Br J Rheumatol 1988;27(suppl. II):90-4.
8. Khalafpour S, Ebringer A, Abuljadayel I, Corbett M. Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondylitis and rheumatoid arthritis patients measured by ELISA. Br J Rheumatol 1988;27(suppl. II):86.
9. Mancini G, Carbonara HO, Heremans JF. Immunological quantification of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-53.
10. Wilson C, Ebringer A, Ahmadi K et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 1995;54:216-20.
11. Takeuchi F, Kosuge E, Matsuta K et al. Antibody to a specific HLA DRβ1 sequence in Japanese patients with rheumatoid arthritis. Arthritis Rheum 1990;33:1867-8.
12. Albani S, Keystone EC, Nelson L. Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nature Med 1995;1:448-52.
13. Fielder M, Tiwana H, Youinou P et al. The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 1995;15:79-82.
14. Subair H, Tiwana H, Fielder M et al. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 1995;22:1825-8.
15. Wilson C, Corbett M, Ebringer A. Increased isolation of Proteus mirabilis species from. rheumatoid arthritis patients compared to osteoarthritis patients and healthy controls. Br J Rheumatol 1990;29(suppl. II):99.
16. McDonagh J, Gray J, Sykes H et al. Anti-Proteus antibodies and Proteus organisms in rheumatoid arthritis: a clinical study. Br J Rheumatol 1994;33:32-5.
17. Kjeldsen-Kragh J, Rashid T, Dywad A et al. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Ann Rheum Dis 1995;54:221-2.
18. Kloppenburg M, Breedveld FC, Terwiel J et al. Minocycline in active rheumatoid arthritis: a double blind, placebo controlled trial. Arthritis Rheum 1994;37:629-36.
19. Langevitz P, Bank I, Zemer D et al. Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol 1992;19:1502-4.